You are here: Home / About Us / School Organization / Office of the Dean / BlouInsight / BlouInsight, January 2012


BlouInsight, January 2012


January 2012
Vol. 5, No. 1

Read the School's strategic planOn January 20, the faculty unanimously approved the School’s new Strategic Plan, which will serve as our guiding document for the next five years. I’d like to thank all of you for your input, engagement, and thoughtful reflection on the plan over the past year. You have contributed tremendously to shaping it. The Strategic Plan articulates our highest aspirations in realizing our shared vision and clearly defines the investments that we must make in molding our future.

The Strategic Plan is now available on the School website and can be found at A PDF of the document is also available for download.

The Strategic Plan opens with our vision, mission, and core values. The core values define who we are and what we believe in—they represent the heart of our people and our School. The strategic initiatives give rise to the School’s future planning efforts and outline our aspirations. The plan is made up of seven strategic initiatives, each comprising from two to eight objectives. The strategic initiatives are

  1. Educational Renaissance: We will transform education, enlighten students, and advance health care.
  2. The Practice of Pharmacy: We will advance the practice of pharmacy, develop pharmacists, and engage stakeholders.
  3. Research and Training Enterprise: We will conduct cutting-edge sponsored research and train the next generation of scientists.
  4. Global Engagement: We will achieve global impact on pharmacy education, research, practice, and health care.
  5. Institutional Environment and Business Operations: We will improve operational efficiencies and maintain a world-class environment.
  6. Our People: We will ensure that the School has the talent and leadership to execute our vision and mission.
  7. Strategic Planning, Assessment, and Quality Improvement: We will foster a culture of strategic planning, assessment, and continuous quality improvement.

The strategic planning process was designed to ensure ongoing planning and assessment. The process requires us to be responsive and adaptable to the internal and external factors that will continue to affect our environment and, inevitably, allow us to create and navigate change. We have purchased TaskStream, an accountability management software package, to guide us in our documentation and tracking of the plan over the next several years. We expect all faculty to be actively involved in implementation and execution of the plan as well as documentation of our progress. Our next step in the planning process is the creation of a development plan, a strategy for securing the resources needed to reach the objectives outlined in the Strategic Plan.

I am very proud of our new Strategic Plan. I want to extend a sincere thank you to each of you for your continued pursuit of excellence in all that you do.


recruitment weekendWe held our annual Graduate Student Recruitment Weekend on January 27 and 28 here at the School. Twenty-one recruits attended and were hosted by an equal number of our current graduate students. Our visitors were treated to two days of tours, information sessions, meals, and other events hosted by the School and our divisions. I would like to thank Assistant Dean Roy Hawke, PharmD, PhD, and Amber Allen, along with GSO President Michael Perfetti, Jasmine Talameh, and all the other graduate students involved for organizing this successful event. (PHOTOS)

The role of the Office of Assessment at the School has been expanded to encompass the School’s new strategic-planning and ongoing programmatic assessment efforts. Mary Roth McClurg, PharmD, MHS, will continue to direct the School’s new Office of Strategic Planning and Assessment. As director, Roth will now report to Vice Dean Russ Mumper, PhD, to reflect the broader role of the new office. Amy Sloane continues in her role as assessment coordinator in the office. As coordinator, she manages the day-to-day operations of the office, including course evaluations; website development and maintenance, annual surveys; data collection, management and reporting; and serves as staff liaison to the Assessment Committee.

The office will work to draft a new, clean-slate vision statement and five-year plan for assessment efforts across the School that will include strategic planning, School-wide institutional effectiveness, and degree-program assessment. The other major responsibilities of the office and its staff include

  • Implementing an academic fellowship program in the office,
  • Monitoring and tracking the progress of the School’s strategic-planning,
  • Ensuring the successful implementation and execution of Strategic Initiative 7 (strategic planning, assessment, and quality improvement) of the School’s strategic plan,
  • Designing and developing a central database to house and archive multiple sources of data used throughout the School for quality improvement,
  • Managing and administering AACP surveys related to curriculum and assessment, and
  • Working with the Office of Professional Education to prepare interim reports for the Accreditation Council for Pharmacy Education.



Amanda Corbett, PharmD, has been promoted to clinical associate professor in the Division of Pharmacotherapy and Experimental Therapeutics. In addition to her appointment in the School, Corbett is a clinical assistant professor in the UNC School of Medicine, a clinical associate for the UNC Center for AIDS Research, and a member of the AIDS Clinical Trials Group Translational Research and Drug Development Scientific Committee, and a pharmacologist for the ACTG.


Stephen Frye, PhD, was promoted to the rank of professor with tenure by the UNC Board of Trustees. Frye is the director of the School’s Center for Integrative Chemical Biology and Drug Discovery, a research group bringing dedicated medicinal chemistry expertise to bear on biological targets of therapeutic relevance under investigation by UNC faculty.


Tim Ives, PharmD, MPH, has been elected as the chair of the Council of Sections for the American Association of Colleges of Pharmacy and will serve on the AACP board of directors as part of his responsibilities. Ives is a professor in PPEE.


Angela Kashuba, PharmD, has been promoted to professor by the UNC Board of Trustees. Kashuba is a member of DPET, director of the UNC Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Core, and director of the pharmacology core of the $32 million UNC Delaney Collaboratory Cure AIDS Project.


Mary Roederer, PharmD, was named pharmacogenomics section adviser for APhA DrugInfoLine’s new “Pharmacogenomics Corner.” Roederer is a research assistant professor in PPEE.


Phil Rodgers, PharmD, has been named as the assistant dean for pharmacy practice partnerships in PPEE. As assistant dean, he will report to Pam Joyner, executive associate dean for professional education, and provide overall leadership and financial oversight for the Professional Experience Program and be heavily engaged in the scholarship of pharmacy practice as well as in developing innovative methods to train students and residents to advance pharmacy practice.


Latasha Weeks, PharmD, has accepted the position of regional assistant dean at Elizabeth City for the UNC Eshelman School of Pharmacy. Weeks is a clinical assistant professor in the Division of Pharmacy Practice and Experiential Education. She will oversee the School’s satellite campus in Elizabeth City, North Carolina, which was created in 2005 in partnership with Elizabeth City State University.


Associate professor Tim Wiltshire, PhD, was granted tenure by the UNC Board of Trustees. Wiltshire joined DPET in 2007 and serves as the associate director of the UNC Institute for Pharmacogenomics and Individualized Therapy. He also holds adjunct faculty positions in the UNC Lineberger Comprehensive Cancer Center and in the Department of Genetics at the UNC School of Medicine. In addition, he is actively involved in several collaborations with the Hamner Institutes for Health Sciences.



Pharmal, the annual semiformal hosted by the UNC Eshelman School of Pharmacy Student Senate, will be held Saturday, February 11, at the Carolina Club in the George Watts Hill Alumni Center. The event will feature a DJ, a cash bar, and plenty of delicious hors d'oeuvres. Tickets are available through Friday, February 10, in the PharMart in Beard Hall from noon to 1:00 p.m. They are $18 each, and checks can be made out to Pharmacy Association. Our students always love to see faculty and staff in attendance.

Jasmine Talameh has been selected as the 2011 recipient of the Kathryne A. Brewington Graduate Student Research Award from the Pharmacy Foundation of North Carolina, Inc..



Cristina Benton, PharmD, PhD, is now a postdoctoral fellow in the School’s Institute for Pharmacogenomics and Individualized Therapy. Benton received her PhD from the School in December and her doctor of pharmacy from Temple University.


Rochelle Hurt is now a full-time member of DPET as an administrative support specialist.


John Kelley is the new executive assistant in the Division of Pharmaceutical Outcomes and Policy. He was previously with the North Carolina Translational and Clinical Sciences Institute.


Shayna McGill, PhD, is a new postdoctoral fellow in the Division of Molecular Pharmaceutics. She comes to us from the College of Pharmacy at the University of Texas at Austin, where she earned her PhD in pharmaceutics. She received her BS from the University of Hawaii.


Michael Stashko is a new research associate with the Division of Chemical Biology and Medicinal Chemistry. He is working in the Center for Integrative Chemical Biology and Drug Discovery in the lab of Bill Janzen. Stashko was a senior research scientist at Abbott Laboratories for sixteen years.


Brenda Braun has joined DPET as a research specialist in the GLP Lab run by Bill Zamboni, PhD. She comes to us from Gilead Sciences, where she worked as an associate scientist in bioanalytical chemistry and the analytical development laboratories for nearly thirteen years.


Kyle Carver, PhD, is a new postdoctoral research associate in MOPH working in the lab of Rudy Juliano, PhD. He received his PhD in physiology and pharmacology from Wake Forest University.

Staff Profile: Brad Wingo

wingoBrad Wingo, MEd, has one semester under his belt as the School’s director of professional student services, but he has had nearly a decade of experience in student affairs. Wingo describes himself as a fan of science and holds an undergraduate degree in biology with a minor in chemistry from North Carolina Wesleyan College. After graduating college, he taught middle school science for a year, and while he knew he wanted to be involved in education, he quickly decided that teaching fifth graders wasn’t for him. This prompted him to adjust his career path by taking the position of premajor adviser in the Student Support Center at N.C. Wesleyan, which was followed by five years as the center’s director. During his time as director, the college was awarded a Title III grant from the U.S. Department of Education that allowed the center to create a number of new initiatives—such as bridge programs, career services, and internships—to expand student support services.

While at Wesleyan, Wingo earned a master’s degree in higher education administration with a concentration in student affairs from North Carolina State University. In 2008, he made the move to NCSU as director of the Student Success and Advising Center and coordinator of advising for the College of Education. There he focused on the development of undergraduate students and promoting the cocurricular experience. When the director of student services position became available here, he says, the School’s reputation drew him here for the opportunity to work with professional students.

Pharmacy students are well past the transition to college and are dealing with a new set of challenges when they enroll at the School. The extremely rigorous curriculum and the talent of their peers can catch some students by surprise when coming from an environment where success perhaps came more easily. Wingo points out that advising is a form of teaching and plays a crucial role in promoting the learning, growth, and success of PharmD students. He wants to help students develop transferable skills and competencies through a personally tailored pharmacy school experience.

As director, Wingo says that every aspect about the cocurricular student experience is fair game for improvement as all current student-service-based practices and programs are being evaluated. The office is working to move to a completely paperless admission process; to strengthen the breadth, depth, and impact of the mentoring and advising programs; and to create professional and career development experiences that poise students for success both while enrolled and after graduation.

Faculty Spotlight: Denise Rhoney, PharmD

RhoneyThe new year brought with it a new chair and associate professor for the Division of Pharmacy Practice and Experimental Education. Denise Rhoney, PharmD, a native of Hickory, North Carolina, joins us from Wayne State University in Detroit, where she had been a member of the faculty since 1995, first in an adjunct position while serving as a clinical assistant professor at the University of Michigan College of Pharmacy and then as an assistant professor of pharmacy practice in 1997. She was promoted to associate professor in 2003. She was also an associate professor in the Department of Neurosurgery at the Wayne State School of Medicine.

Rhoney’s primary clinical interest is in neurocritical care, which deals with life-threatening diseases of the nervous system. Her research has been in the area of stroke, particularly intracerebral hemorrhage (bleeding within the brain tissue itself), and has focused on the disposition of the central nervous system and the action of therapeutic agents delivered into intracerebral clots. She has globally studied effectiveness-based projects of medical interventions in the neurocritical care population that has included subpopulations of traumatic brain injury, status epileptics, and stroke. She is the author or coauthor of more than 120 papers and fifteen book chapters, as well as the recipient of a number of teaching and precepting awards from Wayne State. Rhoney is a fellow of the American College of Clinical Pharmacy and of the American College of Critical Care Medicine. She is also a licensed pharmacist in Michigan and Kentucky.

She received her BS in pharmacy and doctor of pharmacy from the University of Kentucky and completed a general clinical pharmacy residency critical care specialty residency at UK. She was a clinical research/drug development fellow and clinical instructor here at the UNC Eshelman School of Pharmacy from 1993 to 1995, with Professor Herb Patterson, PharmD, serving as her preceptor.

Document Actions

Filed under: ,